Capillary Technologies Intrinsic Value

Capillary Technologies (CAPILLARY) median intrinsic value is ₹431.76 from 9 valuation models (range ₹168–₹1121), vs current price ₹560.55 — -23.0% downside (Trading Above Calculated Value), margin of safety -29.8%. For current market price and key ratios, visit Capillary Technologies screener.

Current Stock Price
₹560.55
Primary Intrinsic Value
₹262.56
Market Cap
₹840.8 Cr
-23.0% Downside
Median Value
₹431.76
Value Range
₹168 - ₹1121
Assessment
Trading Above Calculated Value
Safety Margin
-29.8%

CAPILLARY Valuation Methods Summary — DCF, Graham Number & P/E

Capillary Technologies intrinsic value across 9 models vs current price ₹560.55 — upside/downside and value range per method. Analyse CAPILLARY shareholder distribution to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹262.56 ₹210.05 - ₹315.07 -53.2% EPS: ₹21.88, Sector P/E: 12x
Book Value Method asset ₹378.67 ₹340.80 - ₹416.54 -32.4% Book Value/Share: ₹378.67, P/B: 1.0x
Revenue Multiple Method revenue ₹475.73 ₹428.16 - ₹523.30 -15.1% Revenue/Share: ₹594.67, P/S: 0.8x
EBITDA Multiple Method earnings ₹1008.00 ₹907.20 - ₹1108.80 +79.8% EBITDA: ₹252.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹878.39 ₹702.71 - ₹1054.07 +56.7% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹168.16 ₹151.34 - ₹184.98 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹180.29 ₹162.26 - ₹198.32 -67.8% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹1121.10 ₹1008.99 - ₹1233.21 +100.0% ROE: 30.3%, P/E Multiple: 16x
Graham Defensive Method conservative ₹431.76 ₹388.58 - ₹474.94 -23.0% EPS: ₹21.88, BVPS: ₹378.67
Method Types: Earnings Asset DCF Growth Dividend Conservative

CAPILLARY Intrinsic Value vs Market Price — All Valuation Models

Capillary Technologies fair value range ₹168–₹1121 vs current market price ₹560.55 across 9 valuation models. Read CAPILLARY dividend payout details for the complete payout history and dividend yield track record.

CAPILLARY Intrinsic Value Analysis — Undervalued or Overvalued?

Capillary Technologies median intrinsic value ₹431.76, current price ₹560.55 — Trading Above Calculated Value by 23.0%, margin of safety -29.8%.

What is the intrinsic value of CAPILLARY?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Capillary Technologies (CAPILLARY) is ₹431.76 (median value). With the current market price of ₹560.55, this represents a -23.0% variance from our estimated fair value.

The valuation range spans from ₹168.16 to ₹1121.10, indicating ₹168.16 - ₹1121.10.

Is CAPILLARY undervalued or overvalued?

Based on our multi-method analysis, Capillary Technologies (CAPILLARY) appears to be trading above calculated value by approximately 23.0%.

CAPILLARY Financial Health — Key Ratios vs Industry Benchmarks

Capillary Technologies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 20.90 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 30.3% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 16.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.06x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

CAPILLARY Cash Flow Quality — Operating & Free Cash Flow

Capillary Technologies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-46 Cr ₹-46 Cr Negative Cash Flow 3/10
March 2024 ₹97 Cr ₹7 Cr Positive Free Cash Flow 7/10
March 2023 ₹-20 Cr ₹-70 Cr Negative Cash Flow 3/10
March 2022 ₹7 Cr ₹-50 Cr Positive Operating Cash Flow 6/10
March 2021 ₹1 Cr ₹-6 Cr Positive Operating Cash Flow 6/10